APIs para investigación e impurezas
Los ingredientes farmacéuticos activos (API) son las sustancias en los medicamentos responsables de sus efectos terapéuticos. En esta sección, encontrarás una amplia variedad de API destinados a uso en investigación. Estos compuestos son esenciales para el desarrollo, prueba y validación de nuevas formulaciones farmacéuticas. En CymitQuimica, ofrecemos API de alta calidad para apoyar la investigación en el descubrimiento y desarrollo de fármacos.
Subcategorías de "APIs para investigación e impurezas"
- Aminoácidos y derivados(12.328 productos)
- Antraquinonas y derivados(405 productos)
- Derivados de Benzimidazol e Imidazol(10.438 productos)
- Derivados de Benzodiazepinas(335 productos)
- Carbohidratos y glucoconjugados(5.016 productos)
- Ésteres y derivados(42.240 productos)
- Ácidos Grasos y Derivados Lipídicos(32.395 productos)
- Flavonoides y Polifenoles(17.087 productos)
- Radicales libres y agentes oxidantes/reductores(213 productos)
- Cetonas y Derivados(2.402 productos)
- Antibióticos naturales y semisintéticos(6.380 productos)
- Nitrilos y Cianoderivados(3.067 productos)
- Nitrosaminas y derivados(55 productos)
- Nucleósidos y Nucleótidos(3.431 productos)
- Fosfatos y Fosfonatos Orgánicos(1.202 productos)
- Sulfonatos y Sulfatos Orgánicos(10.434 productos)
- Organometálicos(4.422 productos)
- Otros(6.292 productos)
- Péptidos y Proteínas(3.153 productos)
- Polímeros y derivados(100 productos)
- Derivados de Purinas y Pirimidinas(8.948 productos)
- Derivados de Quinazolina y Quinolina(65.966 productos)
- Quinonas y derivados(24.349 productos)
- Sales y derivados de API(79.696 productos)
- Esteroides y derivados(4.975 productos)
- Sulfonamidas y derivados(2.594 productos)
- Terpenoides y derivados(3.846 productos)
- Tiazolidinedionas y Tiopiranos(2.752 productos)
- Compuestos β-adrenérgicos(230 productos)
Mostrar 21 subcategorías más
Se han encontrado 57012 productos de "APIs para investigación e impurezas"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
N-Nitroso Desmethyl Clomipramine Solution (1 mL ) (N-(3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-N-methylnitrous amide)
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C18H20ClN3OForma y color:Colorless LiquidPeso molecular:329.12949N-Nitroso Moxifloxacin Solution (1 mL ) (1-Cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-1-nitrosooctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFórmula:C21H23FN4O5Forma y color:Light Yellow LiquidPeso molecular:430.16525Bis(4-(2-phenylpropan-2-yl)phenyl)amine (Bis[4-(2-phenylpropan-2-yl)phenyl]amine)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFórmula:C30H31NForma y color:White PowderPeso molecular:405.24565N-Nitroso Safinamide Solution (1 mL ) ((2S)-2-[[[4-[(3-Fluorophenyl)methoxy]phenyl]methyl]nitrosoamino]propanamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C17H18FN3O3Forma y color:Colorless LiquidPeso molecular:331.13322N-Nitroso Levofloxacin Solution (1 mL ) ((3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-nitroso-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C17H17FN4O5Forma y color:Light Brown Light Yellow LiquidPeso molecular:376.1183Tetracosane (n-Tetracosane)
CAS:Saturated acyclic hydrocarbons, excluding ethane and butaneFórmula:C24H50Forma y color:White Crystalline SolidPeso molecular:338.39125N-Nitroso Desmethyl Cyclobenzaprine Solution (1 mL ) (N-[3-(5H-Dibenzo[a,d][7]annulen-5-ylidene)propyl]-N-methylnitrous amide)
Compounds with other nitrogen function, nesoiFórmula:C19H18N2OForma y color:Colorless LiquidPeso molecular:290.14191Lauryldiethanolamine (2,2'-(dodecylazanediyl)bis(ethan-1-ol))
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C16H35NO2Forma y color:Colorless LiquidPeso molecular:273.26678Edaravone Dimer (5,5'-Dimethyl-2,2'-diphenyl-2,2',4,4'-tetrahydro-3H,3'H-[4,4'-bipyrazole]-3,3'-dione)
CAS:Aromatic or modified aromatic compounds containg an unfused pyrazolering (whether or not hydrogenated) in the structureFórmula:C20H18N4O2Forma y color:Off-White PowderPeso molecular:346.14298N-(2,6-Dimethylphenyl)-2-(4-nitrosopiperazin-1-yl)acetamide Solution (1 mL ) (N-(2,6-Dimethylphenyl)-2-(4-nitrosopiperazin-1-yl)acetamide)
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C14H20N4O2Forma y color:Clear LiquidPeso molecular:276.15863Tetraethylene Glycol (2,2'-[Oxybis(2,1-ethanediyloxy)]bis[ethanol])
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFórmula:C8H18O5Forma y color:Colorless LiquidPeso molecular:194.11542N-Nitroso Perindopril Solution (1 mL ) ((2S,3aS,7aS)-1-(N-((S)-1-ethoxy-1-oxopentan-2-yl)-N-nitroso-L-alanyl)octahydro-1H-indole-2-carboxylic acid)
Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFórmula:C19H31N3O6Forma y color:Colorless LiquidPeso molecular:397.22129N-Nitroso Desalkyl Quetiapine Solution (1 mL ) (11-(4-nitrosopiperazin-1-yl)dibenzo[b,f][1,4]thiazepine)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C17H16N4OSForma y color:Colorless LiquidPeso molecular:324.10448N-Nitroso Desmethyl Brompheniramine Solution (1 mL ) (N-(3-(4-Bromophenyl)-3-(pyridin-2-yl)propyl)-N-methylnitrous amide)
Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C15H16BrN3OForma y color:Colorless LiquidPeso molecular:333.04767N-Nitroso N-Methyl Valacyclovir Solution (1 mL ) (2-((2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)ethyl N-methyl-N-nitroso-L-valinate)
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C14H21N7O5Forma y color:Colorless LiquidPeso molecular:367.16042N,N'-Dinitroso Benzathine Solution (1 mL ) (N1,N2-Dinitroso-N1,N2-bis(phenylmethyl)-1,2-ethanediamine)
CAS:Compounds with other nitrogen function, nesoiFórmula:C16H18N4O2Forma y color:Clear Colorless LiquidPeso molecular:298.14298N-Nitroso Sertraline Solution (1 mL ) (N-((1S,4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl)-N-methylnitrous amide)
CAS:Compounds with other nitrogen function, nesoiFórmula:C17H16Cl2N2OForma y color:Colorless LiquidPeso molecular:334.063974-(2-Hydroxyethoxy)phenyl 2-Hydroxy-2-propyl ketone (2-Hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methylpropan-1-one)
CAS:Ketone-phenols and ketones with other oxygen functionFórmula:C12H16O4Forma y color:Off-White PowderPeso molecular:224.10486Cinnamic Acid E/Z (3-Phenylacrylic acid)
CAS:Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives, nesoiFórmula:C9H8O2Forma y color:White PowderPeso molecular:148.05243Nilotinib Related Compound D
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C18H16N4O2Forma y color:Yellow Yellowish-Brown SolidPeso molecular:320.12733
